EA202191382A1 - PLASMA KALLIKREIN-BINDING PROTEINS AND THEIR APPLICATION FOR THE TREATMENT OF HEREDIENT ANGIONEUROTIC EDEMA - Google Patents

PLASMA KALLIKREIN-BINDING PROTEINS AND THEIR APPLICATION FOR THE TREATMENT OF HEREDIENT ANGIONEUROTIC EDEMA

Info

Publication number
EA202191382A1
EA202191382A1 EA202191382A EA202191382A EA202191382A1 EA 202191382 A1 EA202191382 A1 EA 202191382A1 EA 202191382 A EA202191382 A EA 202191382A EA 202191382 A EA202191382 A EA 202191382A EA 202191382 A1 EA202191382 A1 EA 202191382A1
Authority
EA
Eurasian Patent Office
Prior art keywords
plasma kallikrein
heredient
treatment
application
binding proteins
Prior art date
Application number
EA202191382A
Other languages
Russian (ru)
Inventor
Юнг Чиунг
Дэниел Дж. Секстон
Кристофер Тенхор
Джон А. Кеннистон
Райан Фосетт
Райан Ярробино
Джозеф Биденкапп
Берт Эйделман
Original Assignee
Дайэкс Корп.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дайэкс Корп. filed Critical Дайэкс Корп.
Publication of EA202191382A1 publication Critical patent/EA202191382A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Настоящее изобретение предлагает белки, связывающие калликреин плазмы, такие как антитела, связывающие активный калликреин плазмы, и способы применения таких белков для лечения наследственного ангионевротического отека.The present invention provides plasma kallikrein binding proteins, such as active plasma kallikrein binding antibodies, and methods of using such proteins to treat hereditary angioedema.

EA202191382A 2014-07-07 2015-01-21 PLASMA KALLIKREIN-BINDING PROTEINS AND THEIR APPLICATION FOR THE TREATMENT OF HEREDIENT ANGIONEUROTIC EDEMA EA202191382A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462021397P 2014-07-07 2014-07-07

Publications (1)

Publication Number Publication Date
EA202191382A1 true EA202191382A1 (en) 2021-12-31

Family

ID=80631168

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191382A EA202191382A1 (en) 2014-07-07 2015-01-21 PLASMA KALLIKREIN-BINDING PROTEINS AND THEIR APPLICATION FOR THE TREATMENT OF HEREDIENT ANGIONEUROTIC EDEMA

Country Status (1)

Country Link
EA (1) EA202191382A1 (en)

Similar Documents

Publication Publication Date Title
EA201691470A1 (en) PROTEINS CONNECTING CALLICREIN PLASMA, AND THEIR APPLICATION FOR THE TREATMENT OF HEREDITARY ANGIONEUROTIC DOMESTIC
EA201991862A1 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES
SA519401522B1 (en) Anti-LAG-3 Antibodies and Compositions
MX2018003936A (en) Anti-pd-1 antibodies and compositions.
PH12019500923A1 (en) Anti-pd-1 antibodies and compositions
MX2018005315A (en) Compositions and methods for treatment of cancer.
EA201891532A1 (en) COMPOSITIONS AND METHODS OF TREATMENT OF HEMOGLOBINOPATHY
EA201990293A1 (en) MULTI-SPECIFIC ANTIBODIES AGAINST CD40 AND CD137
EA201890285A1 (en) ANTIBODIES AGAINST PD-1, ACTIVATED ANTIBODIES AGAINST PD-1 AND METHODS OF THEIR APPLICATION
EA201791460A1 (en) N4-HYDROXYCYTIDINE AND RELATED DERIVATIVES AND OPTIONS FOR ANTI-VIRUS APPLICATION
EA201891200A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
MX2018010295A (en) Antibodies having specificity for btla and uses thereof.
EA201890131A1 (en) IMMUNOMODULATION AND TREATMENT OF SOLID TUMORS BY ANTIBODIES THAT SPECIFICALLY CONNECT CD38
EA201791867A1 (en) BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS
EA201990296A1 (en) ANTIBODIES AGAINST SIGLEC-7 FOR CANCER TREATMENT
EA201790413A1 (en) ANTIBODIES AGAINST TIGIT
EA201692539A1 (en) ANTIBODIES AND ANTIGENS-BINDING FRAGMENTS, WHICH SPECIFICALLY CONNECT WITH THE PROUCH OF TAU ASSOCIATED WITH MICROTUBULES
EA201890754A1 (en) CONNECTIONS AND METHODS OF THEIR APPLICATION
EA201590388A1 (en) METHODS OF TREATMENT OF Taupathy
EA201790273A1 (en) FLAGELLIN COMPOSITIONS AND THEIR APPLICATION
EA201691610A8 (en) ANTI-JAGGED1 ANTIBODIES AND METHODS OF APPLICATION
EA201591786A1 (en) GLA MONOTHERAPY FOR APPLICATION IN CANCER TREATMENT
EA201890810A1 (en) COMPOUNDS EFFECTIVE FOR THE TREATMENT OF HEPATOTOXICITY AND LIVER STEATOSIS AND THEIR APPLICATION
BR112017013568A2 (en) fused bicyclic compounds for treating diseases
EA201592203A1 (en) METHODS OF TREATMENT OF Taupathy